China became the first in the world to approve the invasive NEO chip for brain-computer interface (BCI). Analysis of the regulatory race, risks, market, and forecasts. Find out who won.
China became the first in the world to approve commercial use of the invasive brain implant NEO. Paralyzed patients can move their hands again. Learn how BCI is changing neurotechnology.
China has commissioned the world's first 30 MW supercritical CO₂ power plant. We analyze engineering risks, corrosion, industrial benefits, and the global context. Find out why this is the 'hydrogen moment' of energy.
In April 2026, solar and wind overtook gas in electricity generation. But this victory comes amid a crisis. Read a detailed analysis of Ember data and forecasts.
French startup Alice & Bob has released Helium, the first upgradable quantum computer with cat qubits. Learn how 18 qubits are changing the quantum race and challenging IBM.
FDA approved vepdegestrant — the first PROTAC degrader for breast cancer with ESR1 mutation. Learn how it destroys resistance and what will change in therapy. Details here.
Despite the failure of the confirmatory study, EMA approved alpelisib for severe PROS syndrome. We analyze the mechanism, risks, and prospects of Vijoice.
Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.
Bukayo Saka brought Arsenal a victory over Atlético (1:0) and a place in the Champions League final. Learn the details of the historic match at the Emirates.
Marcia Kilgore launches the first physical Beauty Pie corner in London. Learn how the retail test is changing the game for DTC brands. Read the details.
FDA approved Vepdegestrant — the first protein degrader tablet for ESR1-mutant breast cancer. PFS 5 months vs 2.1 for fulvestrant. Learn why this is a paradigm shift.
EMA has approved for the first time Jascayd (nerandomilast) for the treatment of idiopathic and progressive pulmonary fibrosis. Advantage of 68.8 mL, mortality reduction of 43%. Learn about the breakthrough in pulmonology.
EMA recommended the first GLP-1 tablet for weight loss — Wegovy (semaglutide) 25 mg. Efficacy up to 16.6% weight loss. Market analysis, winners and losers. Learn more.
EMA issued a positive opinion on the first oral GLP-1 Wegovy for weight loss. Analysis of efficacy, price, side effects and market forecast. Read details.
Vegas crushed Colorado 4-0 and advanced to the 2026 Stanley Cup Final. Carter Hart saved 95% of shots. Get match details, statistics, and predictions.
From the web
Show more
https://ri.vivaaerobus.com/en/?locale=en
We serve leisure passengers, those visiting family and friends (“VFR”), and business travelers, offering flights to more than 179 destinations in Mexico, the United States, Central and South America. In 2025, we closed the year with 104 aircraft and revenue of US$2,376 million.
Exclusive-Mexico to Approve Viva-Volaris Airline Merger by ...
Oct 13, 2026 · MEXICO CITY, Oct 13 (Reuters) - Mexico's antitrust authority is set to approve the planned merger between low-cost carriers Volaris and Viva Aerobus before the end of this year, according ...
Exclusive-Mexico to approve Viva-Volaris airline merger by ...
Oct 13, 2026 · By Natalia Siniawski, Diego Oré and Kylie Madry MEXICO CITY, Oct 13 (Reuters) - Mexico’s antitrust authority is set to approve the planned merger between low-cost carriers Volaris and Viva ...
Apr 3, 2026 · Mexico’s Volaris– Viva Aerobus merger raises cross-border antitrust and US aviation regulatory issues for carriers in the US–Mexico market.
Viva Official Site | Cheap tickets and flights in Mexico
https://www.vivaaerobus.com/en-us/
Plan your next trip with any of our services. Apply for HSBC Viva Credit Cards and enjoy exclusive perks like a free seat and checked bag. Apply for HSBC Viva Cards and travel with exclusive perks. Important! Restrictions for U.S.-bound passengers recently in DRC, Uganda, and South Sudan. Read more.